tiprankstipranks
Trending News
More News >
Callan JMB, Inc. (CJMB)
NASDAQ:CJMB
US Market

Callan JMB, Inc. (CJMB) AI Stock Analysis

Compare
10 Followers

Top Page

CJMB

Callan JMB, Inc.

(NASDAQ:CJMB)

Select Model
Select Model
Select Model
Neutral 43 (OpenAI - 5.2)
Rating:43Neutral
Price Target:
$1.00
▼(-31.03% Downside)
The score is driven primarily by sharply deteriorated financial performance (deep TTM losses and heavy cash burn) and bearish technical conditions (price below major moving averages with negative MACD). Valuation contributes minimally because P/E and dividend yield are unavailable, limiting valuation-based support for the score.
Positive Factors
Recurring Revenue Mix
A material subscription component to revenue creates durable, predictable cash inflows and improves lifetime value per customer. Over months this supports planning, retention-driven growth and upsell opportunities versus pure project work, reducing revenue volatility if churn is managed.
Balance Sheet Cushion
Having positive shareholder equity and only moderate debt provides financial flexibility to absorb near-term losses, pursue restructuring or working capital needs, and access additional financing if necessary. This cushion supports survival while strategic fixes are implemented.
Stable Gross Margin
A mid-30s gross margin suggests the core software and consulting offerings retain unit economics that can support profitability at scale. If operating expenses are controlled and revenue mix shifts toward higher-margin subscriptions, the company has a route to sustainably improve operating margins.
Negative Factors
Severe Cash Burn
Sustained negative operating and free cash flow imposes a structural funding requirement beyond short-term cycles. Over several months this increases reliance on external capital or asset sales, raising dilution or refinancing risk and constraining investment in product, sales, or R&D.
Deep Net Losses
Losses that materially exceed revenue reflect a business model currently destroying economic value. Persisting at this scale would erode equity, impair reinvestment capacity, and likely force structural changes such as cost cuts, asset sales, or capital raises that dilute stakeholders and limit strategic options.
Worsening Leverage and ROE
Increasing leverage alongside a deeply negative ROE signals rising financial risk and weaker returns to shareholders. Over the medium term this can raise borrowing costs, reduce access to favorable financing, and limit ability to invest in growth initiatives until profitability and cash flow recover.

Callan JMB, Inc. (CJMB) vs. SPDR S&P 500 ETF (SPY)

Callan JMB, Inc. Business Overview & Revenue Model

Company DescriptionCallan JMB, Inc. (CJMB) is a dynamic company operating in the technology and consulting sectors, specializing in providing innovative software solutions and strategic advisory services to businesses across various industries. With a focus on enhancing operational efficiency and driving digital transformation, CJMB offers a suite of products that includes cloud-based applications, data analytics tools, and customized consulting services tailored to meet the unique needs of its clients.
How the Company Makes MoneyCJMB generates revenue primarily through three key streams: software sales, consulting services, and subscription-based models for its cloud solutions. Software sales involve direct transactions for proprietary applications, while consulting services are billed on a project basis or through retainers for ongoing advisory support. Additionally, the company has developed a subscription model for its cloud-based offerings, providing clients with continuous access to software updates and support, which contributes to recurring revenue. Strategic partnerships with technology providers and industry leaders further enhance CJMB's market reach and credibility, allowing for collaborative projects that also drive additional income.

Callan JMB, Inc. Financial Statement Overview

Summary
The company faces significant financial challenges with declining revenues and profitability. The income statement shows a substantial net loss, while the balance sheet reflects a decrease in equity and assets. Cash flow analysis indicates potential liquidity issues, although positive free cash flow is maintained.
Income Statement
The income statement shows a concerning decline in revenue and profitability. The gross profit margin has decreased significantly, and the company has moved from a positive net income in previous years to a substantial net loss in the most recent year. The negative EBIT and EBITDA margins indicate operational inefficiencies and potential challenges in cost management.
Balance Sheet
The balance sheet reflects a moderate financial position with a relatively low debt-to-equity ratio, suggesting manageable leverage. However, the substantial decrease in stockholders' equity and total assets raises concerns about the company's ability to sustain its operations and growth. The equity ratio remains strong, indicating a solid capital structure despite recent declines.
Cash Flow
Cash flow analysis reveals a significant decline in operating cash flow and free cash flow compared to previous years, indicating potential liquidity issues. The free cash flow to net income ratio has deteriorated, reflecting challenges in converting income into cash. Despite these concerns, the company has managed to maintain positive free cash flow, which is a positive aspect.
BreakdownTTMDec 2024Dec 2023Dec 2022
Income Statement
Total Revenue5.91M6.56M13.20M22.77M
Gross Profit2.17M2.56M5.65M9.45M
EBITDA-6.48M-2.12M2.30M6.37M
Net Income-6.66M-2.29M2.18M6.22M
Balance Sheet
Total Assets7.74M5.08M9.71M15.25M
Cash, Cash Equivalents and Short-Term Investments2.79M2.10M5.16M6.19M
Total Debt2.07M907.45K400.00K410.88K
Total Liabilities3.56M1.91M910.27K1.24M
Stockholders Equity4.18M3.17M8.80M14.01M
Cash Flow
Free Cash Flow-5.23M494.19K6.51M8.94M
Operating Cash Flow-4.61M540.35K7.00M9.36M
Investing Cash Flow-616.90K-46.17K-490.02K-422.49K
Financing Cash Flow5.21M-3.55M-7.54M-4.57M

Callan JMB, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.45
Price Trends
50DMA
4.34
Negative
100DMA
4.65
Negative
200DMA
Market Momentum
MACD
-0.26
Positive
RSI
29.52
Positive
STOCH
25.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CJMB, the sentiment is Negative. The current price of 1.45 is below the 20-day moving average (MA) of 3.85, below the 50-day MA of 4.34, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 25.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CJMB.

Callan JMB, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
60
Neutral
$3.07M0.1718.17%22.89%-46.58%
52
Neutral
$14.08M
43
Neutral
$6.43M
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CJMB
Callan JMB, Inc.
1.19
-5.13
-81.17%
SGLY
Singularity Future Technology
0.74
-1.71
-69.78%
ATXG
Addentax Group
0.43
-0.28
-39.86%
PSIG
PS International Group
4.32
0.93
27.43%
GVH
Globavend Holdings Ltd.
1.33
-148.67
-99.11%
NCEW
New Century Logistics (BVI) Ltd.
7.40
-8.12
-52.32%

Callan JMB, Inc. Corporate Events

Executive/Board ChangesShareholder Meetings
Callan JMB Holds Annual Meeting, Elects Directors and Auditor
Positive
Dec 31, 2025

At its virtual annual meeting of shareholders held on December 29, 2025, Callan JMB Inc., a Nevada corporation, reported that approximately 68.6% of its outstanding common shares were represented, either virtually or by proxy. Shareholders elected five directors—Wayne Williams, Eric Kash, Mark Meller, Liberty Duke, and Gerald Dial—to serve one-year terms expiring at the 2026 annual meeting, and ratified the appointment of Rosenberg Rich Baker Berman, P.A. as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, reinforcing continuity in both board leadership and external audit oversight.

The most recent analyst rating on (CJMB) stock is a Hold with a $1.50 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.

Regulatory Filings and Compliance
Callan JMB Updates Insider Trading Policy
Neutral
Dec 8, 2025

On December 8, 2025, Callan JMB Inc., a Nevada corporation, announced an amendment to its insider trading policy. The update changes the blackout period to start on the 20th day of the third calendar month of each fiscal quarter, extending until the first full trading day after the company’s financial results are publicly disclosed. This adjustment aims to align the policy with the company’s financial reporting schedule, potentially impacting how stakeholders engage with the company’s stock.

The most recent analyst rating on (CJMB) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.

Executive/Board Changes
Callan JMB Appoints Christopher Shields as Interim CFO
Neutral
Dec 5, 2025

Callan JMB, Inc., a Nevada-based company, has appointed Christopher Shields as the Interim Chief Financial Officer and Treasurer effective December 1, 2025. Shields, who has been with the company since April 2025 as Senior Vice President of Governmental Affairs, brings extensive experience from his previous role at the Chicago Department of Public Health. The company has not yet determined any changes to Shields’s compensation, but he will continue his current duties alongside the new role, with an annual base salary and potential incentive bonuses.

The most recent analyst rating on (CJMB) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Callan JMB, Inc. stock, see the CJMB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 09, 2026